DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

ImmunoGen (NASDAQ: IMGN)

company name or ticker

Update: ImmunoGen Earnings

ImmunoGen Shares Surge 30% Following Earnings

ImmunoGen's (IMGN) CEO Daniel Junius on Q2 2015 Results - Earnings Call Transcript

ImmunoGen, Inc. Gets Into the Black, Accounting Wise

But it's still burning cash.

ImmunoGen (IMGN) Q4 2014 Results - Earnings Call Webcast

Earnings Scheduled For January 30, 2015

Earnings Peek: ImmunoGen Is Undervalued

Why ImmunoGen, Inc. Stock Was Decimated in December

ImmunoGen was the worst biotech stock in December after it and its partner Roche released disappointed study data. Find out whether the mauling was merited or if ImmunoGen shares could be a bargain here.

ImmunoGen: MARIANNE Failed? A Hair Raising Perspective

Perilous Reversal Stock: Immunogen (IMGN)

See More Articles...